Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

News Industry News

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

July 14, 2021

News Conference News PCR London Valves 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Michael O'Riordan

November 25, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

Shelley Wood

August 24, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Conference News TCT 2015

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

Advertisement

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Debating the Role of T-TEER in the Sickest Patients

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

New-Generation Watchman FLX Maintains Good Results Through 2 Years

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

Super-Responders in COAPT: Improving MR and QoL Is Key

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

MITRA-FR: No Benefit of MitraClip in Functional MR

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

Use of LAA Occlusion in Low-Risk Patients Debated

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content